Telephone versus in-person genetic counseling for hereditary cancer risk: Patient predictors of differential outcomes

1. Robson, ME, Bradbury, AR, Arun, B, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2015; 33: 3660–3667.
Google Scholar | Crossref | Medline | ISI2. Domchek, SM, Aghajanian, C, Shapira-Frommer, R, et al. Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. Gynecol Oncol 2016; 140: 199–203.
Google Scholar | Crossref | Medline | ISI3. Daly, MB, Pal, T, Berry, MP, et al. NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021.  https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf (2021, accessed 1 September 2021).
Google Scholar4. US Preventive Services Task Force , Owens, DK, Davidson, KW, et al. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement. JAMA 2019; 322: 652–665.
Google Scholar | Crossref | Medline5. Abacan, M, Alsubaie, L, Barlow-Stewart, K, et al. The global state of the genetic counseling profession. Eur J Hum Genet 2019; 27: 183–197.
Google Scholar | Crossref | Medline6. Hoskovec, JM, Bennett, RL, Carey, ME, et al. Projecting the supply and demand for certified genetic counselors: A workforce study. J Genet Couns 2018; 27: 16–20.
Google Scholar | Crossref | Medline7. Stoll, K, Kubendran, S, Cohen, SA. The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicine. Am J Med Genet C Semin Med Genet 2018; 178: 24–37.
Google Scholar | Crossref | Medline8. Buchanan, AH, Rahm, AK, Williams, JL. Alternate service delivery models in cancer genetic counseling: A mini-review. Front Oncol 2016; 6: 120.
Google Scholar | Crossref | Medline9. Mahon, SM . Telegenetics: Remote counseling during the COVID-19 pandemic. Clin J Oncol Nurs 2020; 24: 244–248.
Google Scholar | Crossref | Medline10. Shannon, KM, Emmet, MM, Rodgers, LH, et al. Transition to telephone genetic counseling services during the COVID-19 pandemic. J Genet Couns 2021; 30: 984–988.
Google Scholar | Crossref | Medline11. Trepanier, AM, Allain, DC. Models of service delivery for cancer genetic risk assessment and counseling. J Genet Couns 2014; 23: 239–253.
Google Scholar | Crossref | Medline12. Unim, B, Pitini, E, Lagerberg, T, et al. Current genetic service delivery models for the provision of genetic testing in Europe: A systematic review of the literature. Front Genet 2019; 10: 552.
Google Scholar | Crossref | Medline13. Interrante, MK, Segal, H, Peshkin, BN, et al. Randomized noninferiority trial of telephone vs in-person genetic counseling for hereditary breast and ovarian cancer: A 12-month follow-up. JNCI Cancer Spectr 2017; 1: pkx002.
Google Scholar | Crossref | Medline14. Peshkin, BN, Kelly, S, Nusbaum, RH, et al. Patient perceptions of telephone vs. in-person BRCA1/BRCA2 genetic counseling. J Genet Couns 2016; 25: 472–482.
Google Scholar | Crossref | Medline15. Jacobs, AS, Schwartz, MD, Valdimarsdottir, H, et al. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer. Fam Cancer 2016; 15: 529–539.
Google Scholar | Crossref | Medline16. Schwartz, MD, Valdimarsdottir, HB, Peshkin, BN, et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol 2014; 32: 618–626.
Google Scholar | Crossref | Medline17. Kinney, AY, Steffen, LE, Brumbach, BH, et al. Randomized noninferiority trial of telephone delivery of BRCA1/2 genetic counseling compared with in-person counseling: 1-year follow-up. J Clin Oncol 2016; 34: 2914–2924.
Google Scholar | Crossref | Medline18. Chang, Y, Near, AM, Butler, KM, et al. Economic evaluation alongside a clinical trial of telephone versus in-person genetic counseling for BRCA1/2 mutations in geographically underserved areas. J Oncol Pract 2016; 12: 59.e1–59.13.
Google Scholar | Crossref19. Drelles, K, Pilarski, R, Manickam, K, et al. Impact of previous genetic counseling and objective numeracy on accurate interpretation of a pharmacogenetics test report. Public Health Genomics 2021; 24: 26–32.
Google Scholar | Medline20. Molina, F, Dehlendorf, C, Gregorich, SE, et al. Women's preferences for and experiences with prenatal genetic testing decision making: sociodemographic disparities in preference-concordant decision making. Patient Educ Couns 2019; 102: 595–601.
Google Scholar | Crossref | Medline21. Hanoch, Y, Miron-Shatz, T, Rolison, JJ, et al. Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy. Psychooncology 2014; 23: 1142–1148.
Google Scholar | Crossref | Medline22. Portnoy, DB, Roter, D, Erby, LH. The role of numeracy on client knowledge in BRCA genetic counseling. Patient Educ Couns 2010; 81: 131–136.
Google Scholar | Crossref | Medline | ISI23. Miron-Shatz, T, Hanoch, Y, Graef, D, et al. Presentation format affects comprehension and risk assessment: The case of prenatal screening. J Health Commun 2009; 14: 439–450.
Google Scholar | Crossref | Medline | ISI24. Beri, N, Patrick-Miller, LJ, Egleston, BL, et al. Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter communication of genetic test results by telephone study. Clin Genet 2019; 95: 293–301.
Google Scholar | Crossref | Medline25. Schifeling, CH, Shanbhag, P, Johnson, A, et al. Disparities in video and telephone visits among older adults during the COVID-19 pandemic: Cross-sectional analysis. JMIR Aging 2020; 3: e23176.
Google Scholar | Crossref | Medline26. Campos-Castillo, C, Anthony, D. Racial and ethnic differences in self-reported telehealth use during the COVID-19 pandemic: a secondary analysis of a US survey of internet users from late March. J Am Med Inform Assoc 2021; 28: 119–125.
Google Scholar | Crossref | Medline27. Butrick, M, Kelly, S, Peshkin, BN, et al. Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genet Med 2015; 17: 467–475.
Google Scholar | Crossref | Medline28. Peshkin, BN, Demarco, TA, Graves, KD, et al. Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: Rationale and development of a randomized controlled trial. Genet Test 2008; 12: 37–52.
Google Scholar | Crossref | Medline29. Berry, DA, Iversen, ES, Gudbjartsson, DF, et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 2002; 20: 2701–2712.
Google Scholar | Crossref | Medline | ISI30. Lipkus, IM, Samsa, G, Rimer, BK. General performance on a numeracy scale among highly educated samples. Med Decis Making 2001; 21: 37–44.
Google Scholar | SAGE Journals | ISI31. Horowitz, M, Wilner, N, Alvarez, W. Impact of event scale: A measure of subjective stress. Psychosom Med 1979; 41: 209–218.
Google Scholar | Crossref | Medline | ISI32. O‘Connor, AM . Validation of a decisional conflict scale. Med Decis Making 1995; 15: 25–30.
Google Scholar | SAGE Journals | ISI33. Erblich, J, Brown, K, Kim, Y, et al. Development and validation of a breast cancer genetic counseling knowledge questionnaire. Patient Educ Couns 2005; 56: 182–191.
Google Scholar | Crossref | Medline34. Cohen, S, Kamarck, T, Mermelstein, R. A global measure of perceived stress. J Health Soc Behav 1983; 24: 385–396.
Google Scholar | Crossref | Medline | ISI35. Garcia-Retamero, R, Galesic, M. Who profits from visual aids: Overcoming challenges in people’s understanding of risks [corrected]. Soc Sci Med 2010; 70: 1019–1025.
Google Scholar | Crossref | Medline | ISI36. Hawley, ST, Zikmund-Fisher, B, Ubel, P, et al. The impact of the format of graphical presentation on health-related knowledge and treatment choices. Patient Educ Couns 2008; 73: 448–455.
Google Scholar | Crossref | Medline | ISI37. Roundtable on Health Literacy, Board on Population Health and Public Health Practice, Institute of Medicine . Health literacy and numeracy: workshop summary. Washington, DC: National Academies Press (US). http://www.ncbi.nlm.nih.gov/books/NBK224816/ (2014, accessed 12 April 2021).
Google Scholar38. Charles, S, Kessler, L, Stopfer, JE, et al. Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Educ Couns 2006; 63: 196–204.
Google Scholar | Crossref | Medline39. National Society of Genetic Counselors . Professional Status Survey 2020: Service Delivery and Access. https://www.nsgc.org/Policy-Research-and-Publications/Professional-Status-Survey (2020, accessed 12 April 2021).
Google Scholar40. Bradbury, AR, Patrick-Miller, L, Long, J, et al. Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility. Genet Med 2015; 17: 485–492.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif